INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, vol.6, no.2, pp.136-140, 2013 (SCI-Expanded)
AIM: To compare the efficacies of subconjunctival bevacizumab, ranibizumab, and pegaptanib sodium injections for the inhibition of corneal neovascularization in an experimental rat model.